LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 11 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $29,843 | -18.2% | 35,956 | -50.0% | 0.00% | – |
Q4 2022 | $36,496 | +82.5% | 71,912 | +100.0% | 0.00% | – |
Q3 2022 | $20,000 | -28.6% | 35,956 | 0.0% | 0.00% | – |
Q2 2022 | $28,000 | -34.9% | 35,956 | +1.3% | 0.00% | – |
Q1 2022 | $43,000 | +2.4% | 35,500 | 0.0% | 0.00% | – |
Q4 2021 | $42,000 | -40.0% | 35,500 | +5.7% | 0.00% | – |
Q3 2021 | $70,000 | -31.4% | 33,600 | 0.0% | 0.00% | – |
Q2 2021 | $102,000 | – | 33,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SANTA MONICA PARTNERS LP | 166,667 | $548,000 | 0.35% |
Almanack Investment Partners, LLC. | 1,042,105 | $3,429,000 | 0.35% |
SABBY MANAGEMENT, LLC | 79,735 | $262,000 | 0.05% |
WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 1,574 | $5,000 | 0.00% |
MORGAN STANLEY | 21,053 | $69,000 | 0.00% |
BlackRock Inc. | 303 | $1,000 | 0.00% |
Citadel Advisors | 23,813 | $79,000 | 0.00% |